OGI News & Events

Organigram Global announced the expansion of its innovation investment in Phylos Bioscience. Through an amended loan and product agreement, Organigram gains priority access to Phylos' autoflower genetics pipeline, including preferential economic terms and long-term rights in its international markets, establishing a foundation for product differentiation and growth in recreational and medical markets. Under the amended product agreement, Organigram receives five-year exclusivity on its chosen autoflower cultivars across international markets, including Canada, Australia, the UK, Germany, and Israel, with the ability to add new exclusive territories as it expands globally. Annual portfolio reviews will maintain exclusivity only for commercially relevant cultivars, maximising flexibility and strengthening Organigram's international product differentiation strategy as it enters high-value medical markets. Under the terms of the amended loan agreement, Organigram will consolidate its existing investment with a new $3M advance, resulting in a combined total loan principal of $10M. The loan matures on May 25, 2028, and is subject to conversion or other resolution mechanisms under the amended agreement.

The major averages had a mixed day as traders reacted to delayed jobs data that could influence the Federal Reserve's interest-rate path next year. Though November's jobs report came in better-than-expected, with an increase of 64,000 jobs for the month, the Bureau of Labor Statistics also reported that 105,000 jobs were shed in October, with the unemployment rate climbing to 4.6%.Record highs earlier in December have given way to a softer backdrop as investors weigh the release of the delayed nonfarm payrolls and other indicators like retail sales and CPI inflation, which were postponed by the longest U.S. government shutdown in history.Looking to commodities, gold was mostly unchanged, while oil fell sharply ahead of API crude numbers set for release this afternoon.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Fordsaid it expectsto "rationalize" U.S. EV-related assetsPfizerreiterated its guidance for FY25 and provided aPayPalhas submitted applications toApplewill expand its iPhone lineup to seven models by 2027,The U.S. Trade Representative said it will use "every tool" to2. WALL STREET CALLS:Rokuto Overweight from Underweight at Morgan StanleyLockheed Martinto Equal Weight at Morgan StanleyOktato Buy at JefferiesStubHubto Market Perform at CitizensWells FargoGapto Overweight3. AROUND THE WEB:Apollo Globalis exploring a potential sale of Atlas Air,Trump is slated to interview Fed governor Christopher Waller on Tuesday for the position of Fed chair,Oraclesigned roughly $150B of data center leases in the three months ending November 30, raising its total data center and cloud capacity commitments to $248B,Metaearned more than $18B in annual ad sales from China in 2024, making up over 10% of its global revenue, with more than $3B linked to fraudulent ads, like for scams,The U.K. government wants Apple, Google, and others to block explicit images at the OS level by default to protect kids and have adults verify their ages,4. MOVERS:Cementos Pacasmayoincreases in New York after announcingof the Hochschild Group, which controls 50.01% of the companyRezolve AIgains in New York afterannual recurring revenue view of $500M or moreAldeyrahigher after announcing thetarget action date for the reproxalap New Drug ApplicationLightwave Logicfalls after announcing anNavanlower after announcing the departure of5. EARNINGS/GUIDANCE:Vestisreaffirmed itsVital Farmsfor FY25Organigram, with Executive Chair Peter Amirault calling fiscal 2025 "marked by purposeful growth"Humanafor FY25CSP Inc., with EPS and revenue higher year-over-yearINDEXES:The Dow fell 302.30, or 0.62%, to 48,114.26, the Nasdaq gained 54.05, or 0.23%, to 23,111.46, and the S&P 500 declined 16.25, or 0.24%, to 6,800.26.